An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Top results in this bookTable of Contents
Cerebral palsy in under 25s: assessment and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)
Ravulizumab (Ultomiris): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with anti-acetylcholine receptor antibody–positive generalized myasthenia gravis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug.
Therapeutic Use of Medical Cannabis in New York State [Internet].
Slawek D, Arnsten JH, Whitley SD, et al.
Baltimore (MD): Johns Hopkins University; 2022 Jan.
Metreleptin (Myalepta): CADTH Reimbursement Recommendation: Indication: As an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy (LD) patients: with confirmed congenital generalised LD (Berardinelli-Seip syndrome) or acquired generalised LD (Lawrence syndrome) in adults and children 2 years of age and above with confirmed familial partial LD (PL) or acquired PL (Barraquer-Simons syndrome), in adults and children 12 years of age and above with persistent significant metabolic disease for whom standard treatments have failed to achieve adequate metabolic control [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 May.
Avalglucosidase Alfa (Nexviazyme): CADTH Reimbursement Recommendation: Indication: For the long-term treatment of patients with late-onset Pompe disease (acid alpha-glucosidase deficiency) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
CADTH Canadian Drug Expert Committee Recommendation: Nusinersen (Spinraza — Biogen Canada Inc.): Indication: Treatment of 5q Spinal Muscular Atrophy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Dec.
CADTH Canadian Drug Expert Committee Recommendation: Nusinersen (Spinraza — Biogen Canada Inc.): Indication: Treatment of 5q spinal muscular atrophy. [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.
Autism spectrum disorder in under 19s: recognition, referral and diagnosis.
London: National Institute for Health and Care Excellence (NICE); 2017 Dec. (NICE Clinical Guidelines, No. 128.)
Community-Based Rehabilitation: CBR Guidelines.
Khasnabis C, Heinicke Motsch K, Achu K, et al., editors.
Geneva: World Health Organization; 2010.
Efgartigimod Alfa (Vyvgart): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
Nusinersen (Spinraza): CADTH Reimbursement Recommendation: Indication: Patients with type II and type III SMA who are older than 18 years of age regardless of ambulatory status [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Aug.
Substance Use Disorder Treatment For People With Physical and Cognitive Disabilities.
Center for Substance Abuse Treatment.
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1998. (Treatment Improvement Protocol (TIP) Series, No. 29.)
ACMG ACT Sheets and Algorithms [Internet].
Bethesda (MD): American College of Medical Genetics and Genomics; 2001-.
Wheelchair provision guidelines [Internet].
Geneva: World Health Organization; 2023.
CADTH Reimbursement Reviews and Recommendations.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013-.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
World Report on Disability 2011.
Geneva: World Health Organization; 2011.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on